Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA: 600420)

Shanghai Shyndec Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	17,006	13,130	9,346	10,650	9,766	9,181
Market Cap Growth	26.94%	40.50%	-12.25%	9.04%	6.38%	-4.90%
Enterprise Value	14,616	10,582	10,423	12,754	11,743	10,392
Last Close Price	12.68	9.60	8.85	9.98	9.06	8.43
PE Ratio	15.71	18.98	14.89	18.74	15.05	13.99
Forward PE	12.68	10.42	10.42	10.42	10.42	10.42
PS Ratio	1.48	1.09	0.72	0.76	0.78	0.75
PB Ratio	1.30	0.92	0.77	1.03	0.99	1.00
P/TBV Ratio	1.42	1.12	0.97	1.35	1.34	1.37
P/FCF Ratio	8.35	9.63	3.67	9.19	8.26	10.60
P/OCF Ratio	7.64	7.63	3.27	6.34	6.26	7.23
PEG Ratio	0.41	0.59	0.59	0.59	0.59	0.59
EV/Sales Ratio	1.27	0.88	0.80	0.91	0.94	0.85
EV/EBITDA Ratio	6.30	5.99	6.24	6.87	6.45	5.59
EV/EBIT Ratio	9.55	10.94	12.39	11.83	10.72	9.13
EV/FCF Ratio	7.18	7.76	4.09	11.01	9.93	12.00
Debt / Equity Ratio	0.07	0.08	0.28	0.40	0.39	0.51
Debt / EBITDA Ratio	0.49	0.64	2.02	2.20	2.09	2.51
Debt / FCF Ratio	0.56	0.84	1.34	3.61	3.22	5.39
Asset Turnover	0.59	0.62	0.67	0.75	0.70	0.72
Inventory Turnover	3.09	3.19	2.94	2.49	2.42	2.69
Quick Ratio	1.61	2.15	2.12	1.09	1.04	1.08
Current Ratio	2.51	2.82	2.78	1.59	1.64	1.49
Return on Equity (ROE)	9.30%	7.28%	7.70%	8.13%	9.46%	10.52%
Return on Assets (ROA)	4.89%	3.10%	2.72%	3.61%	3.81%	4.17%
Return on Capital (ROIC)	6.04%	3.90%	3.49%	4.78%	4.98%	5.64%
Earnings Yield	6.37%	5.27%	6.72%	5.34%	6.64%	7.15%
FCF Yield	11.97%	10.38%	27.27%	10.88%	12.10%	9.44%
Dividend Yield	1.57%	1.04%	1.13%	1.00%	1.10%	1.19%
Payout Ratio	21.82%	27.37%	29.42%	37.39%	32.42%	49.44%
Buyback Yield / Dilution	-9.07%	-10.13%	1.82%	0.14%	-2.42%	-5.45%
Total Shareholder Return	-7.50%	-9.09%	2.95%	1.14%	-1.32%	-4.27%

Source: S&P Capital IQ. Standard template. Financial Sources.